LDC has been awarded Private Equity Investor of the Year at the HealthInvestor Awards, following significant investments in healthcare companies to support their growth and strategic initiatives.
Target Information
LDC has been recognized as the Private Equity Investor of the Year at the prestigious HealthInvestor Awards held at the Grosvenor House Hotel in London. This accolade highlights LDC's significant contributions and successes in the health and social care sectors. During the evaluation period for the awards, LDC executed three notable transactions in the healthcare domain, culminating in over £400 million invested over the last decade, with a combined enterprise value of more than £900 million upon entry.
Among these strategic investments, LDC acquired Medray Group in July 2024, a prominent provider of diagnostic imaging equipment, and Bullen Healthcare in September 2024, the largest independent dispensing appliance contractor in the UK specializing in stoma, urology, and wound care products. These investments aim to bolster the ambitious growth trajectories of these companies. Furthermore, LDC facilitated the merger between its portfolio company, Connect Health, and Healthshare, another specialist healthcare provider, enhancing their operational scale.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The healthcare industry in the UK has been experiencing robust growth due to increasing demand for innovative healthcare solutions and technologies. Rising life expectancy combined with an aging populatio
Similar Deals
Aya Healthcare → Locum’s Nest
2025
Foresight Group → MyWay Digital Health Ltd
2025
Keensight Capital → Bedfont Scientific
2025
Telemos Capital → Helios
2024
Calibre Scientific → Greyhound Chromatography and Allied Chemicals Ltd.
2024
Calibre Scientific → Invitech Ltd.
2024
LDC
invested in
Medray Group
in 2024
in a Other Private Equity deal
Disclosed details
Enterprise Value: $900M